18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma
<p><strong>Purpose</strong> The purpose of this study was to compare the use of fluorine-18-fluorodeoxyglucose (18F-FDG) PET with computed tomography (CT) and dynamic contrast-enhanced (DCE) MRI to predict prognosis and monitor treatment in malignant pleural mesothelioma.</p>...
Main Authors: | Hall, DO, Hooper, CE, Searle, J, Darby, M, White, P, Harvey, JE, Braybrooke, JP, Maskell, NA, Masani, V, Lyburn, ID |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams and Wilkins
2018
|
Similar Items
-
Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
by: Jun Hyeok Lim, et al.
Published: (2020-01-01) -
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
by: M. Pavic, et al.
Published: (2020-07-01) -
Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016-05-01) -
The association between pleural fluid exposure and survival in pleural mesothelioma
by: Asciak, R, et al.
Published: (2021) -
Differentiation Between the Malignant Mesothelioma of Pleura and Pleural Metastasis with Contrast Enhanced CT, Is It Possible?
by: Krittachat Butnian, et al.
Published: (2021-09-01)